UniProt ID | Protein Name ▲ | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A4W5JWG3 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
|
1 | 0 |
|
A0A4W5K0W0 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
|
1 | 0 |
|
A0A4W5JW42 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
|
1 | 0 |
|
A0A4W5JK92 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
|
1 | 0 |
|
A0A4W5JW23 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
|
1 | 0 |
|
A0A4W5JHJ7 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
|
1 | 0 |
|
A0A4W5QT83 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
|
1 | 0 |
|
A0A4W5QLC3 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
1 | 0 |
|
A0A4W5QHE9 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
1 | 0 |
|
A0A4W5MX89 | Beta-secretase 2 |
|
1 | 0 |
|
A0A4W5MUH5 | Beta-secretase 2 |
|
1 | 0 |
|
A0A4W5MSL7 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A4W5MT53 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A4W5MT64 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A4W5MQL5 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A4W5MN56 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A4W5MQM0 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A4W5MUI2 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A4W5NEB3 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A4W5RGD5 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A4W5MFV1 | Hyaluronidase |
|
1 | 0 |
|
A0A4W5S0R3 | Hyaluronidase |
|
1 | 0 |
|
A0A4W5QUC1 | Hyaluronidase |
|
1 | 0 |
|
A0A4W5RY71 | Hyaluronidase |
|
1 | 0 |
|
A0A4W5S0P9 | Hyaluronidase |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024